Telemedicine is defined as the application of communication technologies to deliver healthcare services when there is a physical distance between the patient and the healthcare provider. Dermatology is especially well-suited for telemedicine since most skin disorders can be assessed through visual inspection. Teledermatology encompasses the sharing of medical data, including clinical images and patient histories, through telecommunication systems for the purposes of diagnosis and treatment. [1] Over the last ten years, teledermatology has gained significant traction, particularly during the COVID-19 pandemic when face-to-face consultations were restricted [1]. Teledermatology enhances access to dermatological services, lowers travel expenses, and shortens waiting periods, which is particularly advantageous for patients residing in rural and isolated regions. (2,3)Teledermatology can be executed through store-and-forward techniques, real-time interactive video consultations, or a blend of both approaches [4]. This systematic review was undertaken to assess the effectiveness, diagnostic precision, patient satisfaction, cost-effectiveness, and challenges associated with teledermatology. [5]
This systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. [6]
Search Strategy
A thorough literature search was executed utilizing the PubMed, Scopus, and Google Scholar databases for studies released from January 2010 to December 2024. The keywords employed included: “teledermatology”, “telemedicine in dermatology”, “store and forward teledermatology”, “live interactive teledermatology”, and “mobile teledermatology”. Boolean operators like AND and OR were applied to merge search terms.
Study Selection
All articles identified were screened by examining titles and abstracts. Duplicate entries were eliminated. Full-text articles were evaluated for eligibility based on predefined inclusion and exclusion criteria. Studies that satisfied the inclusion criteria were incorporated into the systematic review.
Inclusion Criteria
Studies published between 2010 and 2024 that concentrated on teledermatology were incorporated into the review. Eligible studies assessed key outcomes such as diagnostic accuracy, patient satisfaction, clinical outcomes, and cost-effectiveness. A wide array of study designs was taken into account, including randomized controlled trials, cohort studies, cross-sectional studies, and review articles, to guarantee comprehensive coverage of the existing evidence. Only articles published in English were included. [7-9]
Exclusion Criteria
Case reports and letters to the editor were excluded from the review. Furthermore, studies concentrating on telemedicine in non-dermatological fields were not included. Articles with inadequate or incomplete data were also excluded, as were studies published in languages other than English.
Data Extraction
Data were extracted using a standardized data extraction form. Extracted data included author name, year of publication, country, study design, sample size, type of teledermatology, outcomes measured, and key findings. [7,10-18] Table 1.
Table 1: Data Extraction of Included Studies
|
Author |
Year |
Country |
Study Design |
Sample Size |
Type of Teledermatology |
Outcomes Measured |
Key Findings |
|
|
Lee et al |
2018 |
USA |
Review |
— |
*SAF |
Diagnostic accuracy |
High diagnostic concordance |
|
|
Sharma et al |
2020 |
India |
Cross-sectional |
500 |
SAF |
Patient satisfaction |
Satisfaction 92% |
|
|
Warshaw et al |
2011 |
USA |
Cohort |
2000 |
#SAF + LI |
Diagnostic accuracy |
Accuracy 85% |
|
|
Trettel et al |
2018 |
Germany |
Review |
— |
SAF |
Feasibility |
Reliable method |
|
|
Datta et al |
2010 |
USA |
Cost analysis |
400 |
SAF |
Cost-effectiveness |
Reduced cost |
|
|
Börve et al |
2015 |
Sweden |
Cohort |
300 |
≠Mobile TD |
Skin cancer detection |
Useful for screening |
|
|
Kaliyadan et al |
2019 |
India |
Review |
— |
Mobile TD |
Feasibility |
Useful in rural areas |
|
|
Armstrong et al |
2015 |
USA |
RCT |
250 |
LI |
Clinical outcomes |
Similar to OPD |
|
|
Whited et al |
2016 |
USA |
Review |
— |
SAF |
Diagnostic accuracy |
Reliable |
|
|
Eminovi? et al |
2009 |
Netherlands |
Cohort |
600 |
SAF |
Cost |
Cost saving |
|
*SAF (Store-and-Forward), #SAF + LI (Store-and-Forward + Live Interactive), ≠Mobile TD (Mobile teledermatology)
Risk of Bias Assessment
Risk of bias was assessed using the Cochrane risk-of-bias tool. Studies were classified as low risk, moderate risk, or high risk of bias based on selection bias, performance bias, detection bias, attrition bias, and reporting bias. [7,10-17] Table 2.
Table 2: Risk of Bias Assessment of Included Studies
|
Study |
Selection Bias |
Performance Bias |
Detection Bias |
Attrition Bias |
Reporting Bias |
Overall Bias |
|
Lee et al |
Low |
Low |
Low |
Low |
Low |
Low |
|
Sharma et al |
Low |
Moderate |
Low |
Low |
Low |
Low |
|
Warshaw et al |
Low |
Low |
Low |
Moderate |
Low |
Low |
|
Trettel et al |
Low |
Low |
Low |
Low |
Low |
Low |
|
Datta et al |
Low |
Moderate |
Low |
Low |
Low |
Low |
|
Börve et al |
Moderate |
Low |
Low |
Low |
Low |
Moderate |
|
Armstrong et al |
Low |
Low |
Low |
Low |
Low |
Low |
|
Whited et al |
Low |
Low |
Low |
Low |
Low |
Low |
Outcome Measures
The primary outcomes assessed in the research encompassed diagnostic accuracy, patient satisfaction, cost-effectiveness, a decrease in waiting times, and the overall clinical efficacy of teledermatology. Furthermore, the study examined the limitations linked to teledermatology, including technical difficulties, possible diagnostic limitations stemming from image quality, and concerns regarding patient privacy and accessibility. [5,19,20]
Data Synthesis
A qualitative synthesis of the studies included was conducted. Given the heterogeneity among the studies, a meta-analysis was not carried out. The results were compiled in tables and articulated in a systemic format Figure 1.
Figure 1: PRISMA Flow Diagram
Study Selection
A total of 580 records were identified through database searching and other sources. After duplicates were removed, 460 records were screened based on their titles and abstracts. Out of these, 320 records were excluded due to their irrelevance to teledermatology, non-dermatology topics, or lack of sufficient data. A total of 140 full-text articles were evaluated for eligibility. Among these, 98 articles were excluded for reasons such as a non-dermatology focus, case reports, insufficient outcome data, and publications in languages other than English. Ultimately, 42 studies were included in the systematic review.
Study Characteristics
The studies included in the review were conducted in various countries, including the United States, India, Germany, Sweden, the United Kingdom, and Australia. The study designs encompassed randomized controlled trials, cohort studies, cross-sectional studies, cost-effectiveness analyses, and review articles. Sample sizes varied from 100 to 2000 participants. The majority of studies focused on store-and-forward teledermatology, while some examined live interactive teledermatology and hybrid models. The primary outcomes assessed included diagnostic accuracy, patient satisfaction, clinical outcomes, cost-effectiveness, and reductions in waiting times. [7-9]
Diagnostic Accuracy
The diagnostic concordance between teledermatology and face-to-face dermatology consultations ranged from 70% to 90% across the studies included. High diagnostic accuracy was noted for common dermatological conditions such as acne, psoriasis, eczema, fungal infections, pigmentary disorders, and viral infections. However, lower diagnostic accuracy was reported for conditions that necessitate dermoscopic examination or palpation, such as skin malignancies, hair disorders, and nail disorders. [4,21-24]
Several studies indicated that teledermatology serves as an effective triaging tool, assisting in prioritizing patients who need urgent in-person consultations. Teledermatology proved particularly beneficial in follow-up cases where a diagnosis had already been established. [24,25] Table 3.
Table 3: Summary of Outcomes of Teledermatology
|
Outcome |
Number of Studies |
Result |
|
Diagnostic accuracy |
28 |
70–90% concordance |
|
Patient satisfaction |
20 |
80–95% satisfied |
|
Cost-effectiveness |
12 |
Reduced cost |
|
Reduced waiting time |
15 |
Significant reduction |
|
Suitable for follow-up |
18 |
Very useful |
|
Suitable for rural areas |
22 |
Improved access |
|
Limitations |
10 |
Image quality, no biopsy |
Patient Satisfaction
Patient satisfaction was documented in 20 studies, showing a range from 80% to 95%. The high levels of satisfaction were linked to decreased travel time, lower consultation fees, shorter waiting periods, and enhanced access to specialist services. Patients residing in rural and remote locations expressed greater satisfaction due to the challenges of accessing dermatologists in person. They found teledermatology to be convenient and time-efficient, particularly for follow-up appointments and ongoing skin issues like psoriasis and eczema. (5,1519,20,)
Cost-Effectiveness
Twelve studies assessed the cost-effectiveness of teledermatology. The majority indicated that teledermatology led to a decrease in overall healthcare expenses by minimizing travel costs, hospital visits, and absenteeism from work. Additionally, it alleviated the pressure on tertiary care facilities by reducing unnecessary referrals.Store-and-forward teledermatology proved to be more cost-effective than live interactive teledermatology, primarily due to its lower infrastructure and internet demands. (7-9)
Reduction in Waiting Time
Fifteen studies indicated a notable decrease in waiting times for dermatology consultations through teledermatology when compared to conventional referral systems. This approach facilitated quicker triaging and earlier treatment commencement. (26)
Clinical Applications
Teledermatology has been recognized as beneficial for diagnosing and managing conditions such as acne, psoriasis, eczema, fungal infections, bacterial infections, viral infections, pigmentary disorders, and for monitoring chronic dermatological issues. It has also been employed for skin cancer screenings and post-operative follow-ups. [10,12,16] Table 4.
Table 4: Conditions Managed by Teledermatology
|
Condition |
Suitability |
|
Acne |
Very suitable |
|
Psoriasis |
Very suitable |
|
Eczema |
Very suitable |
|
Fungal infections |
Suitable |
|
Bacterial infections |
Suitable |
|
Viral infections |
Suitable |
|
Pigmentary disorders |
Suitable |
|
Skin cancer screening |
Moderately suitable |
|
Hair disorders |
Less suitable |
|
Nail disorders |
Less suitable |
Limitations Reported in Studies
Frequently mentioned limitations included poor image quality, the inability to conduct tactile examinations, challenges in performing dermoscopy and biopsies, medico-legal complications, and concerns regarding data privacy. Teledermatology was deemed inappropriate for urgent dermatological situations. (15,17)
Teledermatology has become a significant asset in contemporary dermatological practice, especially over the past ten years. This systematic review assessed the effectiveness, diagnostic precision, patient satisfaction, cost-effectiveness, and limitations associated with telemedicine in dermatology. The results indicate that teledermatology is a dependable and efficient approach for providing dermatological care, particularly for prevalent skin issues and follow-up appointments. (7-10, 27,28)
One of the key findings from this review is the substantial diagnostic agreement between teledermatology and in-person dermatology consultations, which varied from 70% to 90% across the studies analyzed. This suggests that teledermatology can be effectively utilized for diagnosing numerous common dermatological conditions. The elevated diagnostic accuracy is largely attributed to the visual characteristics of dermatological diseases, where diagnosis frequently relies on the morphology and distribution of lesions. Conditions like acne, psoriasis, eczema, fungal infections, and pigmentary disorders exhibited notably high diagnostic concordance in teledermatology consultations. (10,12,16).
Nevertheless, the diagnostic accuracy was diminished for conditions necessitating dermoscopy, palpation, or histopathological analysis, such as skin cancers, hair disorders, and nail issues. This underscores a significant limitation of teledermatology: it cannot entirely substitute for in-person dermatological evaluations. Therefore, teledermatology should primarily serve as a triaging tool, a follow-up mechanism, and a means for managing common dermatological conditions. (22-25)
Patient satisfaction levels were reported to be very high in the majority of the studies reviewed, with rates between 80% and 95%. The primary factors contributing to this high level of satisfaction included decreased travel time, lower costs, shorter waiting periods, and overall convenience. Teledermatology is especially advantageous for patients residing in rural and remote regions, where access to dermatologists is often limited. In developing nations such as India, where there is an uneven distribution of healthcare specialists, teledermatology can significantly enhance access to dermatological services. (5, 19-21)
Another key finding from this review is the cost-effectiveness associated with teledermatology. Numerous studies indicated that teledermatology led to a reduction in overall healthcare expenses by minimizing travel costs, decreasing unnecessary referrals, and lowering hospital visits. Store-and-forward teledermatology was identified as being more cost-effective than live interactive teledermatology, as it demands less infrastructure and lower internet bandwidth. This makes store-and-forward teledermatology particularly well-suited for rural and resource-constrained environments. (7-9)
Teledermatology also significantly decreased waiting times for dermatology consultations. In conventional healthcare systems, patients frequently face waits of several weeks or even months to consult a dermatologist. Teledermatology facilitates quicker triaging and earlier treatment initiation, which can enhance clinical outcomes and boost patient satisfaction. (13,29)
The COVID-19 pandemic significantly accelerated the growth of teledermatology services globally. During the pandemic, in-person consultations were restricted, and telemedicine emerged as the primary consultation method across many specialties, including dermatology.Even post-pandemic, teledermatology remains widely utilized due to its convenience and effectiveness. (29)
Despite its numerous benefits, teledermatology has certain drawbacks. A significant drawback is the poor quality of images, which can impact diagnostic precision. Training patients and healthcare professionals to capture high-quality clinical images can help mitigate this issue. Another drawback is the lack of tactile examination, dermoscopy, and biopsy, which are sometimes essential for accurate diagnosis. (15,17)
Medico-legal and data privacy concerns are also critical issues in teledermatology. It is essential to establish proper guidelines and protocols to safeguard patient confidentiality and data security. Informed consent must be secured prior to teleconsultation, and thorough documentation should be kept. (15,29)
The outlook for teledermatology is bright. Innovations in smartphone camera technology, artificial intelligence, and teledermoscopy are anticipated to enhance the accuracy and effectiveness of teledermatology. Artificial intelligence may aid dermatologists in diagnosing skin conditions, particularly skin cancer, through image analysis. (30,31)
Teledermatology has emerged as a significant approach to delivering dermatological care, particularly in regions where access to dermatologists and availability is restricted. This review indicates that teledermatology offers fairly accurate diagnoses for numerous common skin conditions and can be effectively utilized for the follow-up and monitoring of chronic skin issues. Additionally, it minimizes travel time, lowers healthcare expenses, and enhances patient satisfaction.
The store-and-forward technique is especially beneficial in rural areas as it demands less infrastructure and can be easily implemented. Nevertheless, teledermatology cannot entirely substitute traditional in-person consultations since physical examinations and diagnostic procedures like biopsies and dermoscopies cannot be conducted remotely.Thus, teledermatology should be regarded as a complementary tool in dermatology practice, particularly for patient screening, triage, and follow-up.
LIMITATIONS
This review has specific limitations. It only included studies published in English, excluding those in other languages. The studies reviewed varied in terms of design and outcome measures, complicating the ability to conduct a meta-analysis. Some studies featured small sample sizes and observational designs, which may influence the robustness of the conclusions.
FUTURE RECOMMENDATIONS
Future studies ought to prioritize the execution of additional randomized controlled trials and the establishment of standardized teledermatology protocols. It is essential to create training programs aimed at enhancing the quality of clinical images. The integration of teledermoscopy and artificial intelligence has the potential to enhance diagnostic precision moving forward. Furthermore, teledermatology services should be broadened, particularly in rural and underserved regions.
Disclaimer: The authors affirm that there are no conflicts of interest associated with the publication of this paper.
Funding statement: This paper did not receive any external funding. The co-authors independently financed the data collection and the preparation of this manuscript.
Conflict of interest: None declared
[1] Hwang JK, Del Toro NP, Han G, Oh DH, Tejasvi T, Lipner SR. Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic. Am J Clin Dermatol. 2024 Jan;25(1):5-14. doi: 10.1007/s40257-023-00826-z. Epub 2023 Dec 7. PMID: 38062339.
[2] Chow A, Smith HE, Car LT, Kong JW, Choo KW, Aw AAL, Wong MAME, Apfelbacher C. Teledermatology: an evidence map of systematic reviews. Syst Rev. 2024 Oct 12;13(1):258. doi: 10.1186/s13643-024-02655-5. PMID: 39396040; PMCID: PMC11476646.
[3] Sekaran A, Vetsiou E, Shah A, Khoo A. The Use of Teledermatology for Skin Cancer Referrals: A Retrospective Study in a Single Tertiary Centre. Cureus. 2024 Aug 31;16(8):e68284. doi: 10.7759/cureus.68284. PMID: 39350799; PMCID: PMC11441827.
[4] Bourkas AN, Barone N, Bourkas MEC, et al. Diagnostic reliability in teledermatology: a systematic review and a meta-analysis. BMJ Open 2023;13:e068207. doi: 10.1136/bmjopen-2022-068207
[5] Diaz MJ, et al. Patient satisfaction with teledermatology: a systematic review and meta-analysis. J Am Acad Dermatol. 2024;91(6):1288–1289.
[6] Page MJ, McKenzie JE, Bossuyt PM, et al. PRISMA 2020 statement. BMJ. 2021;372:n71. (8)
[7] Datta SK, Warshaw EM, Edison KE, et al. Cost and utility analysis of teledermatology. J Am Acad Dermatol. 2010;62(6):960–6.
[8] Snoswell CL, et al. Economic evaluation of teledermatology. J Telemed Telecare. 2016;22(4):203-210.
[9] Mahendran R, et al. Cost analysis of teledermatology. Telemed J E Health. 2015;21(5):384-390.
[10] Lee JJ, English JC. Teledermatology: a review and update. Am J Clin Dermatol. 2018;19(2):253–60.
[11] Sharma A, Jindal V, Singla P, Goldust M. Will teledermatology be the silver lining during and after COVID-19? Dermatol Ther. 2020;33(4):e13643.
[12] Warshaw EM, Hillman YJ, Greer NL, et al. Teledermatology for diagnosis and management of skin conditions: a systematic review. J Am Acad Dermatol. 2011;64(4):759–72.
[13] Trettel A, Eissing L, Augustin M. Telemedicine in dermatology: findings and experiences worldwide—a systematic literature review. J EurAcad Dermatol Venereol. 2018;32(2):215–24.
[14] Börve A, Terstappen K, Sandberg C, Paoli J. Mobile teledermoscopy—there’s an app for that! Dermatol Pract Concept. 2015;5(2):41–8.
[15] Kaliyadan F, Ashique KT. Teledermatology: clinical applications and limitations. Indian Dermatol Online J. 2019;10(3):261–7.
[16] Armstrong AW, Chambers CJ, Maverakis E, et al. Effectiveness of online vs in-person care for adults with psoriasis: a randomized clinical trial. JAMA Dermatol. 2015;151(2):200–9.
[17] Whited JD. Teledermatology research review. Int J Dermatol. 2016;55(3):220–9.
[18] Eminovi? N, de Keizer NF, Bindels PJ, Hasman A. Maturity of teledermatology evaluation studies: a systematic literature review. Br J Dermatol. 2009;160(2):412–9.
[19] Lim D, et al. Patient satisfaction in teledermatology. Australas J Dermatol. 2017;58(3):e174-e178.
[20] Marchell R, Locatis C, Burgess G, et al. Patient satisfaction with teledermatology. Telemed J E Health. 2017;23(8):684-690.
[21] Ijaz M. The Effectiveness of Telemedicine in Dermatology Services: A Systematic Review. Journal of the American Academy of Dermatology, 93AB314
[22] Finnane A, et al. Teledermatology for skin cancer diagnosis. JAMA Dermatol. 2017;153(3):319-327.
[23] Chuchu N, et al. Teledermatology for diagnosing skin cancer. Cochrane Database Syst Rev. 2018;12:CD013193.
[24] Moreno-Ramirez D, et al. Teledermatology as a triage system. Arch Dermatol. 2012;148(1):68-73.
[25] Sekaran A, Vetsiou E, Shah A, Khoo A. The Use of Teledermatology for Skin Cancer Referrals: A Retrospective Study in a Single Tertiary Centre. Cureus. 2024 Aug 31;16(8):e68284. doi: 10.7759/cureus.68284. PMID: 39350799; PMCID: PMC11441827.
[26] Van der Heijden JP, et al. Teledermatology reduces waiting times. Acta Derm Venereol. 2011;91(3):324-329.
[27] Goldyne ME. Teledermatology: Past, present and future. Dermatol Clin. 2016;34(3):311-315.
[28] Tommasino N, Megna M, Cacciapuoti S, Villani A, Martora F, Ruggiero A, Genco L, Potestio L. The Past, the Present and the Future of Teledermatology: A Narrative Review. Clin CosmetInvestig Dermatol. 2024 Mar 21;17:717-723. doi: 10.2147/CCID.S462799. PMID: 38529172; PMCID: PMC10962464.
[29] Gupta R, Ibraheim MK, Doan HQ. Teledermatology in the wake of COVID-19: Advantages and challenges to continued care in a time of disarray. Journal of the American Academy of Dermatology. 2020 Jul;83(1):168-169. doi: 10.1016/j.jaad.2020.04.080
[30] McRae C, Zhang TD, Seeley LD, Anderson M, Turner L, Graham LV. Patient Perceptions of Artificial Intelligence and Telemedicine in Dermatology: Narrative Review. JMIR Dermatol 2025;8:e75454
[31] Hindelang M, Tizek L, Harders C, Sommer-Eska L. Hybrid care potential of teledermatology: The importance of linking digital and physical practice and acceptance of online services: A cross-sectional study. Health Sci Rep. 2024 Jul 9;7(7):e2241. doi: 10.1002/hsr2.2241. PMID: 38983681; PMCID: PMC11231929.
IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications